Suppr超能文献

老年痴呆症患者药物减量决策中的伦理问题。

Ethical Aspects of Physician Decision-Making for Deprescribing Among Older Adults With Dementia.

机构信息

Johns Hopkins University School of Medicine, Baltimore, Maryland.

Institute for Health Research, Kaiser Permanente Colorado, Aurora.

出版信息

JAMA Netw Open. 2023 Oct 2;6(10):e2336728. doi: 10.1001/jamanetworkopen.2023.36728.

Abstract

IMPORTANCE

Physicians endorse deprescribing of risky or unnecessary medications for older adults (aged ≥65 years) with dementia, but there is a lack of information on what influences decisions to deprescribe in this population.

OBJECTIVE

To understand how physicians make decisions to deprescribe for older adults with moderate dementia and ethical and pragmatic concerns influencing those decisions.

DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional national mailed survey study of a random sample of 3000 primary care physicians from the American Medical Association Physician Masterfile who care for older adults was conducted from January 15 to December 31, 2021.

MAIN OUTCOMES AND MEASURES

The study randomized participants to consider 2 clinical scenarios in which a physician may decide to deprescribe a medication for older adults with moderate dementia: 1 in which the medication could cause an adverse drug event if continued and the other in which there is no evidence of benefit. Participants ranked 9 factors related to possible ethical and pragmatic concerns through best-worst scaling methods (from greatest barrier to smallest barrier to deprescribing). Conditional logit regression quantified the relative importance for each factor as a barrier to deprescribing.

RESULTS

A total of 890 physicians (35.0%) returned surveys; 511 (57.4%) were male, and the mean (SD) years since graduation was 26.0 (11.7). Most physicians had a primary specialty in family practice (50.4% [449 of 890]) and internal medicine (43.5% [387 of 890]). A total of 689 surveys were sufficiently complete to analyze. In both clinical scenarios, the 2 greatest barriers to deprescribing were (1) the patient or family reporting symptomatic benefit from the medication (beneficence and autonomy) and (2) the medication having been prescribed by another physician (autonomy and nonmaleficence). The least influential factor was ease of paying for the medication (justice).

CONCLUSIONS AND RELEVANCE

Findings from this national survey study of primary care physicians suggests that understanding ethical aspects of physician decision-making can inform clinician education about medication management and deprescribing decisions for older adults with moderate dementia.

摘要

重要性

医生支持为患有痴呆症的老年患者(年龄≥65 岁)减少风险或不必要的药物剂量,但对于影响此类人群减少药物剂量的决策因素知之甚少。

目的

了解患有中度痴呆症的老年患者的医生在做出减少药物剂量的决策时的考虑因素,以及影响这些决策的伦理和实际问题。

设计、地点和参与者:这是一项横断面全国邮寄调查研究,对象为美国医学协会医师名录中的 3000 名初级保健医生,他们为老年人提供医疗服务。该研究于 2021 年 1 月 15 日至 12 月 31 日进行。

主要结果和测量

研究将参与者随机分配到 2 种临床情况下,医生可能会决定减少患有中度痴呆症的老年人的药物剂量:1 种情况下,如果继续使用药物可能会导致药物不良反应,另一种情况下则没有证据表明该药物有益。参与者通过最佳最差标度法(从减少药物剂量的最大障碍到最小障碍)对 9 个与可能的伦理和实际问题相关的因素进行了排名。条件逻辑回归量化了每个因素作为减少药物剂量的障碍的相对重要性。

结果

共有 890 名医生(35.0%)返回了调查问卷;其中 511 名(57.4%)为男性,毕业后的平均(SD)年限为 26.0(11.7)年。大多数医生的主要专业是家庭医学(50.4%[890 名中的 449 名])和内科(43.5%[890 名中的 387 名])。共有 689 份调查足够完整,可以进行分析。在这两种临床情况下,减少药物剂量的 2 个最大障碍是(1)患者或家属报告药物有症状获益(有利和自主)和(2)药物是由另一位医生开的(自主和非伤害)。最不具影响力的因素是药物的支付便利性(公正)。

结论和相关性

这项针对初级保健医生的全国性调查研究的结果表明,了解医生决策中的伦理方面可以为教育临床医生如何管理药物以及为患有中度痴呆症的老年患者做出减少药物剂量的决策提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e98/10548310/9539da5a1abf/jamanetwopen-e2336728-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验